GenTrust’s Lexaria Bioscience LEXX Stock Holding History

GenTrust’s Portfolio LEXX Stock Details LEXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-60,000	Closed	-$183K	–	213
2024 Q3	$183K	Hold	60,000	–	–	0.01%	197
2024 Q2	$167K	Buy	+60,000	New	+$180K	0.01%	174

Other funds holding LEXX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GenTrust's LEXX Position: Q4 2024 in Review

GenTrust sold out of Lexaria Bioscience (LEXX) in Q4 2024, closing a stake of 60,000 shares — an estimated $183K sold.

GenTrust first reported a position in LEXX in Q2 2024 and held it in 2 quarters. The position peaked at $183K in Q3 2024. 25 funds tracked by Wall St. Rank hold LEXX as of Q4 2024.

GenTrust reported no remaining Lexaria Bioscience position as of Q4 2024 after selling out during the quarter.
GenTrust sold 60,000 Lexaria Bioscience shares in Q4 2024, an estimated $183K.
GenTrust first reported a position in Lexaria Bioscience in Q2 2024 and held it in 2 quarters.
GenTrust's Lexaria Bioscience position peaked at $183K in Q3 2024.
25 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q4 2024.

Based on GenTrust's 13F filing for Q4 2024, filed 5 Feb 2025.